Afmedica, Inc.Acquired by Angiotech Pharmaceuticals, Inc
Afmedica, Inc. is a drug delivery company formed in early 2002 to commercialize new technologies that are the derivatives of the anti-proliferative drug eluting stent successfully commercialized by Johnson and Johnson in conjunction with the Company’s founders. Afmedica’s intellectual property platform supports a variety of novel medical uses of the FDA approved anti-proliferative agent Sirolimus. Afmedica’s first product is a polymer wrap that focuses on preserving the vascular graft in patients with End Stage Renal Disease (ESRD) who require a vascular access for chronic hemodialysis.

Co-InvestorsApjohn Group, Apjohn Ventures, angels

Afmedica in the news

 

Brill Street + CompanyWebsite: http://www.brillstreet.com

Brill Street helps client companies fill short-term, part-time and full-time project needs to address resource shortages quickly and affordably. Its unique temporary staffing solution gives businesses with backlogs and long "to do" lists the opportunity to utilize top college talent, while providing the studentswith the experiential learning they crave. The Company’s On-Demand Staffing service is also ideal for addressing "gaps" in your team, when you have difficult positions to fill or when you have temporary absences. In these situations, Brill Streeters come on board to complete projects and keep bottlenecks from occurring until a position is filled permanently or absent staff returns.

Co-InvestorsCeres Ventures, OCA Ventures

Brill Street + Company in the news

 

HistoSonics Website: http://www.histosonics.com  

HistoSonics mission is to become the leading non-invasive surgical technology and market leader. HistoSonics platform technology has the potential to replace traditional surgical and minimally invasive modalities with a totally non-invasive modality, Histotripsy, that will reduce patient trauma and healthcare costs significantly.

Inspire Website: http://www.inspiresleep.com  

Inspire Medical Systems, based in Minneapolis, Minnesota, is the leading developer of innovative, implantable neurostimulation systems to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy which is designed to improve sleep and enrich the lives of people suffering from this challenging condition.

InStadium Website: http://www.instadium.com  

InStadium, Inc. is a sports marketing and advertising company providing local and national brands game-day advertising and promotions within Major League Baseball and National Football League stadiums. The Company has long term media rights with 19 MLB (including Yankee Stadium and Fenway Park) and 7 NFL teams. This base provides a platform that includes 20 of the top advertising markets in the U.S., including 16 of the Top 25 DMAs.

Co-InvestorsAlerion Partners, Hopewell Ventures, HQ Investments, angels

InStadium in the news

InterRad Medical Website: http://www.interradmedical.com

InterRad Medical is developing a proprietary catheter anchoring device called SecurAcath Catheter Retention System. The SecurAcath System is a new and unique method for holding catheters in place over and extended time. Currently, long term use catheters are secured on the surface of a patient’s skin with sutures or adhesive devices which can lead to site infection or skin irritation. The SecurAcath System utilizes a very small anchor that deploys just under the skin to hold a catheter securely in place.

Co-InvestorsAngels and doctors

InterRad in the news

MedElute, Inc. MedElute, Inc. is a start-up based in Michigan that has been granted a paid up license from Angiotech Pharmaceutical, Inc. as part of the merger transaction between Angiotech and Afmedica, Inc. The license is for rights to a pending patent (not yet issued) in which claims are made for methods and materials to treat post surgical adhesions with a highly novel anti-platelet approach.

Co-InvestorsApjohn Group, Apjohn Ventures and angels

MedVantx, Inc. Website: http://www.medvantx.com

MedVantx, Inc. developed and markets an electronic interactive point-of-care system that facilitates the issuance of generic drug and OTC samples by physicians.

The automated Sample Centertm provides labeling, patient education materials, HIPPA compliant patient record inputs, and generates utilization and tracking reports for the physician and insurance companies.

The Company’s state-of-the art on-line pharmacy, AmeriPharm, along with its proprietary ValuePointRXtm patient management program, facilitates the appropriate utilization of generics and OTCs to the benefit of employers, health insurers, physicians and consumers.

Co-InvestorsAdvent International, Arch Ventures, CID Ventures, Dow Chemical, HQ Investments, Ironwood Ventures, McKesson Corporation, Polaris Ventures, Rock Maple Ventures, Seneca Ventures, Walgreens

MedVantx in the news